Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-10-16

Clinical Trial Update: Does Vildagliptin Affect Portal Vein Pressure In Patients With Type 2 Diabetes Mellitus? A Cross Sectional Study

View source ↗

Summary

A completed cross-sectional study assessed whether vildagliptin influences portal vein pressure in patients with type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vildagliptin (Galvus) (vildagliptin)

Snippet

Sponsor: Bezmialem Vakif University | Conditions: Drug Mechanism, Drug Usage | Status: COMPLETED